Results 171 to 180 of about 5,434 (205)

Metamizol

Alexander Bott, Marika Busse, Maximilian Waldner   +2 more
openaire   +2 more sources

Agranulocytosis attributed to metamizole: An analysis of spontaneous reports in EudraVigilance 1985‐2017

Basic and Clinical Pharmacology and Toxicology, 2020
Falk Hoffmann, Carsten Bantel, Kathrin Jobski   +2 more
exaly  

Metamizol

Der Schmerz, 2015
openaire   +1 more source

Antinociceptive Synergy Between Metamizole and Hesperidin in a Model of Visceral Pain in Mice

Archives of Medical Research, 2021
Rosa Ventura-Martinez, Myrna Déciga-Campos, Maria Eva González-Trujano   +2 more
exaly  

Metamizol as a cause of postoperative erythroderma

Contact Dermatitis, 2004
N, Bernedo, M T, Audicana, O, Uriel, M, Velasco, G, Gastaminza, E, Fernández, D, Muñoz   +6 more
openaire   +2 more sources

Pharmacokinetics of metamizol metabolites.

Agents and actions. Supplements, 1986
When administered to humans, metamizol rapidly undergoes predominantly nonenzymatic biotransformation, yielding a vast number of active and later inactive metabolites. The biotransformational pathways and the clinical significance of the metabolites are discussed in the light of their individual pharmacokinetics.
openaire   +1 more source

Metamizole

2006
openaire   +1 more source

Metamizole (Dipyrone) and the Liver: A Review of the Literature

Journal of Clinical Pharmacology, 2019
Mathias Lutz
exaly  

28 Metamizol

2019
Volker Wanka, Stefan Weiß
openaire   +1 more source

Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data

Naunyn-Schmiedeberg's Archives of Pharmacology, 2019
Inke R KÖNIG, Roland Linder, Markus Schwaninger   +2 more
exaly